Through precise portion control, Macro Foods enhances the effectiveness of GLP-1 in promoting satiety and controlling glucose levels
The arginate form also offers advantages for systemic applications where the researcher wants broad distribution rather than localized effects
For instance, a study published in The New England Journal of Medicine found that individuals taking semaglutide lost an average of 14.9% of their body weight over 68 weeks, compared to just 2.4% in the placebo group
The evidence base, however, is narrow and almost entirely preclinical
We also examined the expression of genes involved in fatty acid synthesis: ACC, PGC-1, PGC-1, C/EBP, FAS, PGC1, and SREBP-1c